Radiopharm Theranostics has raised A$35 million through a private placement led by Lantheus Holdings, Inc. The funds will be used for the development of radiopharmaceutical products.
Amount Raised
A$35 Million
Round Type
Post-IPO Equity
SydneyBiotechnologyHealth CareMedicalInvestors
Description
Radiopharm Theranostics Limited has secured A$35 million in a private placement from international and Australian institutional investors, including Lantheus Holdings, Inc. Furthermore, the company is launching a Share Purchase Plan to raise an additional A$5 million for eligible shareholders. The funds from both initiatives will support the company’s development efforts. Chief Executive Officer Riccardo Canevari expressed satisfaction with the successful fundraising.
Quick answer
Radiopharm Theranostics raised A$35 Million in a Post-IPO Equity round, dated October 20, 2025. Investors: Lantheus Holdings and Lantheus Holdings, Inc. Radiopharm Theranostics is based in Sydney, New South Wales, Australia.
- How much did Radiopharm Theranostics raise?
- Radiopharm Theranostics raised A$35 Million in a Post-IPO Equity round on October 20, 2025.
- Who invested in Radiopharm Theranostics?
- Lantheus Holdings and Lantheus Holdings, Inc. are named as investors in this round.
- What does Radiopharm Theranostics do?
- Radiopharm Theranostics is developing a world-class platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses.
- Where is Radiopharm Theranostics based and how big is it?
- Radiopharm Theranostics is based in Sydney, New South Wales, Australia. Fundz records about 14 employees.
- Who are the decision-makers at Radiopharm Theranostics?
- Fundz holds 1 contact at Radiopharm Theranostics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Radiopharm Theranostics that raised within 45 days of this round, from Fundz verified event records.
- Radical Health raised $5M (Pre-Seed) on December 4, 2025.
- Kestra Medical Technologies raised $159M (Post-IPO Equity) on December 4, 2025.
- Annette raised $2.3M (Seed) on December 4, 2025.
- Ray Studios raised $12M (Funding Round) on December 3, 2025.
- a2z Radiology AI raised $1.5M (Pre-Seed) on December 2, 2025.
- GE HealthCare Technologies raised $1.3B (Debt Financing) on December 2, 2025.
Who to call at Radiopharm Theranostics, and when
A new round usually means Radiopharm Theranostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Radiopharm Theranostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Radiopharm Theranostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Radiopharm Theranostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Radiopharm Theranostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Radiopharm Theranostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.